Replies to post #308 on Cocrystal Pharma Inc (COCP)

[UHD]

"ENGLEWOOD CLIFFS, NJ--(Marketwired - December 02, 2013) - BioZone Pharmaceuticals, Inc. (OTCQB: BZNE) announced today that it has enhanced its balance sheet significantly by eliminating outstanding convertible preferred stock. In the recent transaction, holders of convertible preferred stock, with a stated value of $3.5 million and a 10% dividend, exchanged their securities for shares of common stock. Key holders expressed the view that the recently announced merger with Cocrystal Discovery, Inc. is a significant positive development for the Company."


http://pharmaceuticals.einnews.com/pr_news/178945248/biozone-pharmaceuticals-inc-enhances-balance-sheet